News
I think IonQ could be a hundred-billion-dollar company and represent this decade’s largest return on investment. There will be casualties and disappointments in this...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
News
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded...
News
This article was written by Follow Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with over 5 years of industry...
News
By Padhraic Garvey, CFA, Regional Head of Research, Americas The US economy continues to refuse to lie down – a key driver of long...
News
Summary European Wax Center (NASDAQ:EWCZ) is a franchisor and operator of out-of-home [OOH] waxing services. Readers may find my previous coverage via this link....
News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
News
Investment action Based on my outlook and analysis of AppLovin Corp. (NASDAQ:APP) 2Q23 results, I recommend a hold rating. I would like to mention...
News
Overview My recommendation for Cadre Holdings (NYSE:CDRE) is a hold rating, as I view the valuation as fairly valued. That said, I am bullish...
News
Investment Thesis Fidelity National Financial (NYSE:FNF) is an insurance company providing a wide range of insurance, financial services, and technical solutions. Through dedicated investment...
News
Investment briefing After breaking the line of support in the ascending channel in its 2022—’23 price rally, the equity stock of Tactile Systems Technology,...
News
NIBE Industrier AB (publ) (OTCPK:NDRBF) Q2 2023 Earnings Conference Call August 17, 2023 5:00 AM ET Company Participants Eric Lindquist – CEO Hans Backman...
News
Taysha Gene Therapies (NASDAQ:TSHA) has made great progress recently in advancing its gene therapy known as TSHA-102 for the treatment of patients with Rett...
